Italian pharmaceutical company DuLac Farmaceutici is intensifying its U.S. market strategy with two key initiatives: the launch of its products on OneLavi.com and participation in the 2026 ECRM Vitamin, Weight Management & Sports Nutrition Session, scheduled for September 14-17 in Palm Beach Gardens, Florida. These moves signal a significant commitment to expanding the company's footprint beyond its initial success on Amazon.
Having established consumer demand through its Amazon U.S. storefront, DuLac is now diversifying its e-commerce channels and preparing to engage with major retailers. The company's Amazon performance has been robust, with Arnica Gel 98% amassing over 13,000 customer reviews and maintaining a 4.5-star rating, while the Dinaven line has garnered more than 4,000 reviews and a 4.6-star average. This traction provides a solid foundation for the company's broader distribution goals.
The addition of OneLavi as a sales channel expands DuLac's reach to a wider American audience, offering another platform for its Made in Italy product portfolio. According to Gabriele Bollani, Founder and CEO of DuLac Farmaceutici, "ECRM comes at an important time for DuLac because we are making a major commitment to the U.S. market. Amazon has demonstrated that American consumers are responding to our products, OneLavi gives us another important U.S. channel, and now we are ready to introduce DuLac to major retailers and build the partnerships that can take our expansion to the next level."
At the ECRM session, DuLac will hold scheduled meetings with buyers from health, specialty, food, drug, and mass retail channels. The company plans to showcase its Italian-developed portfolio, which includes high-concentration Arnica Gel 98%, Dinaven, and Diosmin lines. These products are developed using proprietary technologies such as Arnica Montana Arricchita™, indoor vertical farming, micronized Diosmin MPFF, and solvent-free Supercritical CO₂ Extraction, all manufactured under GMP and ISO quality standards.
DuLac's expansion strategy is multi-faceted, combining its established Amazon presence, new e-commerce partnerships, and direct retail engagement. The company's goal is to build a diversified U.S. presence across various distribution channels, introducing more American consumers to its pharmaceutical-grade wellness products. With over 30 years of pharmaceutical industry expertise, DuLac is leveraging its Italian heritage and advanced manufacturing to compete in the U.S. market.
As DuLac moves forward, its participation in ECRM and partnership with OneLavi are pivotal steps toward national distribution. The company is transitioning from initial market entry to a comprehensive expansion, aiming to secure shelf space in major retailers and establish long-term relationships with U.S. partners. This strategic approach underscores DuLac's commitment to becoming a significant player in the American wellness market.
